Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2Dermatologic 1Breast 1

Conditions

Neoplasm Metastasis 1Meningioma 1Glioma 1Central Nervous System Vascular Malformations 1Brain Neoplasms 1Aneurysm 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Laser Speckle Contrast Imaging × CNS × Clear all
NCT05028400 2022-04-12

LSCI-NSURG

Insel Gruppe AG, University Hospital Bern

Phase NA Completed
20 enrolled
CNS

Aneurysm, Glioma, Meningioma, Neoplasm Metastasis, Central Nervous System Vascular Malformations

NCT00632437 2012-07-30

Intraoperative Optical Imaging of Brain Function

M.D. Anderson Cancer Center

Withdrawn
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡